中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

82 records (took 0.017 seconds)

    Food production
    32.
    发明授权
    Food production 失效
    食品生产

    公开(公告)号：US4738853A

    公开(公告)日：1988-04-19

    申请号：US719953

    申请日：1985-04-04

    Applicant: David F. Horrobin

    Inventor： David F. Horrobin

    IPC: A23K1/16 ,  A23K1/18 ,  A23K1/00

    CPC classification number: A23K50/75 ,  A23K20/158 ,  Y10S426/807

    Abstract: A method of maintaining hens or other domesticated birds for egg production, comprises giving the birds feed supplemented with .gamma.-linolenic acid or one or more higher acids in the n-6 series, in the form of the free acid or as an ester, amide, phospholipid, salt or other physiologically acceptable derivative convertible in the bird's body to, or having the effect of, the free acid.

    Abstract translation: 维持母鸡或其他驯养的鸡用于产蛋的方法包括以游离酸形式或作为酯酰胺给予在n-6系列中补充有γ-亚麻酸或一种或多种高级酸的鸟饲料 ，磷脂，盐或其他生理学上可接受的衍生物在鸟体内转化为或具有游离酸的作用。

    Treatment of fatigue, head injury and stroke
    35.
    发明授权
    Treatment of fatigue, head injury and stroke 失效
    疲劳，头部损伤和中风的治疗

    公开(公告)号：US06441038B1

    公开(公告)日：2002-08-27

    申请号：US09686629

    申请日：2000-10-12

    Applicant: Cari Loder ,  David F. Horrobin

    Inventor： Cari Loder ,  David F. Horrobin

    IPC: A61K31195

    CPC classification number: A61K31/55 ,  A61K45/06 ,  A61K2300/00

    Abstract: A method of treatment of disorders of neurological origin and drug formulations for use in the method are disclosed. These conditions comprise fatigue and associated syndromes of pain, weakness and depressed mood which are associated with chronic fatigue syndrome, brain injury and stroke, stress, fibromyalgia, and irritable bowel syndrome. The treatment comprises administering to a patient in need thereof a selective inhibitor of noradrenaline reuptake combined with either phenylalanine or tyrosine in the same dosage form or the same pack.# The noradrenergic drug may be selected from lofepramine, desipramine or reboxetine. The selective inhibitor may be a combined inhibitor of both noradrenaline and serotonin reuptake such as venlafaxine, duloxetine or milnacipran, or an inhibitor of both noradrenaline and dopamine reuptake such as bupropion.

    Abstract translation: 公开了一种治疗神经源性疾病的方法和用于该方法的药物制剂。 这些病症包括与慢性疲劳综合征，脑损伤和中风，压力，纤维肌痛和肠易激综合征相关的疲劳和相关的疼痛，虚弱和抑郁情绪综合征。 该治疗包括向有需要的患者施用去甲肾上腺素再摄取的选择性抑制剂与相同剂型或相同包装中的苯丙氨酸或酪氨酸组合。＃去甲肾上腺素能药可以选自洛哌匹灵，地昔帕明或瑞波西汀。 选择性抑制剂可以是去甲肾上腺素和5-羟色胺再摄取的组合抑制剂，如文拉法辛，度洛西汀或米那普仑，或去甲肾上腺素和多巴胺再摄入如安非他酮的抑制剂。

    Fatty acid treatment
    36.
    发明授权
    Fatty acid treatment 失效
    脂肪酸处理

    公开(公告)号：US5888541A

    公开(公告)日：1999-03-30

    申请号：US784105

    申请日：1997-01-15

    Applicant: David F. Horrobin ,  Brenda E. Reynolds

    Inventor： David F. Horrobin ,  Brenda E. Reynolds

    IPC: A61K31/201 ,  A61K35/78 ,  A61K9/20

    CPC classification number: A61K31/201

    Abstract: Increase gut calcium absorption in humans or animals by the administration of GLA, DGLA or LA as such or in salt or other pharmacologically acceptable form, optionally in association with EPA, DHA or other EFA in similar forms, specifically useful in the treatment of osteoporosis.

    Abstract translation: 通过施用GLA，DGLA或LA本身或以盐或其他药理学上可接受的形式，任选地与EPA，DHA或其他类似形式的EFA相关联地增加对人或动物的肠吸收钙吸收，特别可用于治疗骨质疏松症。

    Method of increasing the total fat content of milk
    39.
    发明授权
    Method of increasing the total fat content of milk 失效
    增加牛奶总脂肪含量的方法

    公开(公告)号：US5264217A

    公开(公告)日：1993-11-23

    申请号：US959472

    申请日：1992-10-09

    Applicant: David F. Horrobin

    Inventor： David F. Horrobin

    IPC: A61K31/20

    CPC classification number: A61K31/20 ,  Y10S514/922

    Abstract: Methods for increasing the total fat and therefore energy content of mammalian and particularly human milk, the essential fatty acid content of that milk and the flow of that milk during lactation, or for preventing or reducing the normal decrease in milk fat content that occurs during prolonged lactation, by administering gamma linolenic acid, dihomo-gamma-linolenic acid or their mixture, alone or a physiologically acceptable diluent or carrier, in a form administrable to the lactating female.

    Abstract translation: 增加哺乳动物和特别是人乳的总脂肪，因此能量含量的方法，该乳的必需脂肪酸含量和哺乳期间该奶的流动，或用于预防或减少在长时间内发生的乳脂含量的正常降低 通过以可施用于哺乳期雌性的形式单独或单独或生理上可接受的稀释剂或载体施用γ-亚麻酸，二亚非 - γ-亚麻酸或其混合物。

Patent Agency Ranking